A double-blind clinical trial of griseofulvin in patients with Raynaud's phenomenon.
D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D006118:Griseofulvin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D010919:Placebos; D011928:Raynaud Disease / Q000188:drug therapy*
D010919:Placebos; D006118:Griseofulvin